PURE Bioscience
OTCPK:PURE
$ 0,09
+ $0,01 (12,50%)
0,09 $
+$0,01 (12,50%)
End-of-day quote: 03/26/2026

PURE Bioscience Stock Value

The analyst rating for OTCPK:PURE is currently sf_Data Unavailable.
-

PURE Bioscience Company Info

EPS Growth 5Y
0,00%
Market Cap
$0,01 B
Long-Term Debt
$0,01 B
Short Interest
2,56%
Quarterly earnings
06/13/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
1992
Industry
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, PURE Bioscience’s Price Target has risen from $3,00 to $3,00 - a 0,00% increase.

Top growth stocks in the materials sector (5Y.)

What does PURE Bioscience do?

PURE Bioscience, Inc. focuses on developing and commercializing proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers residual protection and formulates well with other compounds. The company offers PUR...
×